A prospective, double-blind trial of somatostatin analog (octreotide) versus glucagon for the inhibition of small intestinal motility during endoscopic retrograde cholangiopancreatography
Jacques Van Dam, Marc F. Catalano, D.Roy Ferguson, David S. Barnes, Gregory Zuccaro Jr., Michael V. Sivak Jr.Volume:
42
Year:
1995
Language:
english
DOI:
10.1016/s0016-5107(95)70130-3
File:
PDF, 467 KB
english, 1995